A comprehensive map of human glucokinase variant activity
Sarah K. GersingiD, Matteo CagiadaiD, Marinella GebbiaiD, Anette P. GjesingiD, Atina G. CotéiD, Gireesh SeesankariD, Roujia Li, Daniel R. TabetiD, Jochen WeileiD, Amelie SteiniD, Anna L. GloyniD, Torben F. HanseniD, Frederick P. RothiD, Kresten Lindorff‐LarseniD, Rasmus Hartmann‐PeterseniD
Abstract
Glucokinase (GCK) regulates insulin secretion to maintain appropriate blood glucose levels. Sequence variants can alter GCK activity to cause hyperinsulinemic hypoglycemia (HH) or hyperglycemia associated with GCK-maturity-onset diabetes of the young (GCK-MODY), collectively affecting up to 10 million people worldwide. Patients with GCK-MODY are frequently misdiagnosed and treated unnecessarily. Genetic testing can prevent this but is hampered by the challenge of interpreting novel missense variants. Here we exploited a multiplexed yeast complementation assay to measure both hyper- and hypoactive GCK variation, capturing 97% of all possible missense and nonsense variants. Activity scores correlated with in vitro catalytic efficiency, fasting glucose levels in carriers of GCK variants and with evolutionary conservation. Hypoactive variants were concentrated at buried positions, near the active site, and at a region of known importance for GCK conformational dynamics. Some hyperactive variants shifted the conformational equilibrium towards the active state through a relative destabilization of the inactive conformation. Our comprehensive assessment of GCK variant activity promises to facilitate variant interpretation and diagnosis, expand our mechanistic understanding of hyperactive variants, and inform development of therapeutics targeting GCK.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 58
- FWCI
- 14.68
- Field percentile
- top 1%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Characterizing glucokinase variant mechanisms using a multiplexed abundance assay
S. Gersing, T. K. Schulze, … R. Hartmann-Petersen·bioRxiv·May 24, 2023
- Expanding the mutational spectrum of GCK in Turkish pediatric population
Vehap Topçu, Gönül Büyükyılmaz, … Mehmet Boyraz·medRxiv·Feb 7, 2024
- Sex-dependent additive effects of dorzagliatin and incretin on insulin secretion in a novel mouse model of GCK-MODY
Shadai Salazar, Luis Fernando Delgadillo-Silva, … Guy A. Rutter·bioRxiv·Nov 9, 2024
- Mapping the GCK-GKRP interaction landscape using deep mutational scanning by reverse two-hybrid screening
Sarah K. Gersing, Sofie Dahl, … Rasmus Hartmann‐Petersen·bioRxiv·Jan 15, 2026
- Polygenic Background Contributes to GCK-MODY Clinical Presentation and Glycaemic Variability
Jacques Murray Leech, Ankit M Arni, … Kashyap Amratlal Patel·DiabetologiaPeer-reviewed·Mar 18, 2026
- Patients with Type 2 Diabetes and a GCK variant are still at risk for T2D-related secondary complications
Kelly M. Schiabor Barrett, Natalie Telis, … Elizabeth T. Cirulli·medRxiv·Dec 19, 2023